|
CCT2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.53069999999844E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.400500E-04 |
| Normal-vs-Stage2 |
2.636200E-03 |
| Normal-vs-Stage3 |
3.68589999999447E-06 |
| Normal-vs-Stage4 |
1.91980000008307E-07 |
| Stage1-vs-Stage2 |
7.446000E-01 |
| Stage1-vs-Stage3 |
1.083220E-01 |
| Stage1-vs-Stage4 |
7.458500E-03 |
| Stage2-vs-Stage3 |
4.114600E-01 |
| Stage2-vs-Stage4 |
1.214430E-01 |
| Stage3-vs-Stage4 |
3.101600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.842370E-04 |
| Normal-vs-AfricanAmerican |
9.024000E-03 |
| Normal-vs-Asian |
1.075050E-03 |
| Caucasian-vs-AfricanAmerican |
9.507400E-01 |
| Caucasian-vs-Asian |
9.770000E-01 |
| AfricanAmerican-vs-Asian |
9.323000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.46110000001742E-06 |
| Normal-vs-Female |
1.631260E-04 |
| Male-vs-Female |
1.159590E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.040400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.55339999999837E-05 |
| Normal-vs-Age(61-80Yrs) |
9.24289999981731E-07 |
| Normal-vs-Age(81-100Yrs) |
2.010600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.624500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.507800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.345400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.029800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.757800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.596400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.846800E-01 |
| Classical-VS-Follicular |
4.421500E-02 |
| Classical-VS-Other |
2.669600E-01 |
| Classical-VS-Normal |
1.953000E-04 |
| Tall-VS-Follicular |
3.879800E-01 |
| Tall-VS-Other |
5.315800E-01 |
| Tall-VS-Normal |
2.942700E-03 |
| Follicular-VS-Other |
9.007000E-01 |
| Follicular-VS-Normal |
3.50490000000647E-05 |
| Other-VS-Normal |
2.016100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.91189999998453E-06 |
| Normal-vs-N1 |
2.30379999999197E-06 |
| N0-vs-N1 |
1.970390E-01 |
|
|
